Uscom Ltd. (UCM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Uscom Ltd. (UCM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7133
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Uscom Ltd. (Uscom) is a medical device company that operates in non-invasive hemodynamic market. It focuses on the development, design, manufacture and marketing of non-invasive cardiac monitoring devices. Uscom’s product portfolio includes its flagship product USCOM 1A (ultrasonic cardiac output monitor) non-invasive, beat to beat, real time cardiac output monitor based on continuous wave Doppler ultrasound; and BP+, a non-invasive automatic blood pressure monitoring device based on supra systolic oscillometric central blood pressure technology. The company operates in the US through its subsidiary, Uscom, Inc. It markets its products the world over through partnerships and distributors. Uscom is headquartered in Sydney, Australia.

Uscom Ltd. (UCM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Uscom Ltd., Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Uscom Ltd., Medical Equipment Deals By Type, 2012 to YTD 2018 7
Uscom Ltd., Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Uscom Ltd., Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Uscom Ltd., Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Uscom Ltd., Medical Equipment, Deal Details 11
Partnerships 11
Deltex Medical And Uscom Enter Distribution Agreement 11
Equity Offering 12
Uscom Raises USD1.3 Million in Private Placement of Shares 12
Uscom Raises USD1.6 Million in Private Placement of Shares 13
Uscom Raises USD0.07 Million in Private Placement of Shares 14
Uscom Raises USD1.1 Million in Private Placement of Shares 15
Uscom to Raise Funds through Share Purchase Plan 16
Uscom Completes Private Placement Of Shares For US$1 Million 17
Uscom Completes Private Placement Of Shares For US$0.03 Million 18
Uscom Announces Private Placement Of Shares For US$0.73 Million 19
Acquisition 20
Uscom Acquires 100% Stake In Thor Labs 20
Uscom Completes Acquisition Of Pulsecor For US$2.4 Million 21
Uscom Ltd. – Key Competitors 23
Uscom Ltd. – Key Employees 24
Uscom Ltd. – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Aug 21, 2018: Uscom: Annual Report 2018 26
Feb 14, 2018: Uscom: Appendix 4D Results and Update 28
Corporate Communications 29
Aug 23, 2018: Uscom appoints Brett Crowley as Non-executive Director of Board 29
May 28, 2018: Uscom expands China operations, secures key appointments 30
May 23, 2018: Uscom Announce Resignation of Mr David He 31
Dec 15, 2017: Uscom receives $492K R&D cash 32
Government and Public Interest 33
Jun 18, 2018: Uscom attends the 19th Annual Duke Anesthesiology Conference in Orlando, Florida 33
Product News 34
May 24, 2018: New US IP for Uscom SpiroSonic Devices 34
Other Significant Developments 35
Jul 31, 2018: Uscom: 4C quarterly cash report to 30 June 2018 35
Jan 31, 2018: Uscom: Appendix 4C Results and Update Quarter ended 31 December 2017 36
Jul 11, 2017: Euro Funding for Uscom Pulmonary Research 37
Jun 01, 2017: Uscom SpiroSonic Devices for Spanish Health Project 39
Jun 01, 2017: Spanish eHealth monitoring of patients with chronic disease using digital Uscom SpiroSonic spirometers and software platform 41
May 24, 2017: Uscom SpiroSonic Devices for French Lung Transplant Study 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Uscom Ltd., Medical Equipment, Key Facts, 2018 2
Uscom Ltd., Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Uscom Ltd., Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Uscom Ltd., Medical Equipment Deals By Type, 2012 to YTD 2018 7
Uscom Ltd., Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Uscom Ltd., Deals By Market, 2012 to YTD 2018 9
Uscom Ltd., Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Deltex Medical And Uscom Enter Distribution Agreement 11
Uscom Raises USD1.3 Million in Private Placement of Shares 12
Uscom Raises USD1.6 Million in Private Placement of Shares 13
Uscom Raises USD0.07 Million in Private Placement of Shares 14
Uscom Raises USD1.1 Million in Private Placement of Shares 15
Uscom to Raise Funds through Share Purchase Plan 16
Uscom Completes Private Placement Of Shares For US$1 Million 17
Uscom Completes Private Placement Of Shares For US$0.03 Million 18
Uscom Announces Private Placement Of Shares For US$0.73 Million 19
Uscom Acquires 100% Stake In Thor Labs 20
Uscom Completes Acquisition Of Pulsecor For US$2.4 Million 21
Uscom Ltd., Key Competitors 23
Uscom Ltd., Key Employees 24
Uscom Ltd., Subsidiaries 25

List of Figures
Uscom Ltd., Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Uscom Ltd., Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Uscom Ltd., Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Uscom Ltd., Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Uscom Ltd., Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Uscom Ltd., Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Uscom Ltd., Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Uscom Ltd., Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Uscom Ltd. (UCM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NAPEC Inc (NPC):企業の財務・戦略的SWOT分析
    NAPEC Inc (NPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Summit Pharmaceuticals International Corp:企業の戦略的SWOT分析
    Summit Pharmaceuticals International Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Olvi plc:企業の戦略・SWOT・財務情報
    Olvi plc - Strategy, SWOT and Corporate Finance Report Summary Olvi plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Jiangsu Jiuding New Material Co., Ltd. (002201):企業の財務・戦略的SWOT分析
    Jiangsu Jiuding New Material Co., Ltd. (002201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Viralytics Ltd (VLA)-製薬・医療分野:企業M&A・提携分析
    Summary Viralytics Ltd (Viralytics), formerly Psiron Ltd is a provider of development and commercialisation of oncolytic immunotherapies. The company develops oncolytic immunotherapies for the treatment of different types of cancers. It offers cavataktm, a proprietary formulation for the common cold …
  • China Mengniu Dairy Co Ltd:企業の戦略・SWOT・財務情報
    China Mengniu Dairy Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Mengniu Dairy Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Al Jaber Group:企業の戦略・SWOT・財務分析
    Al Jaber Group - Strategy, SWOT and Corporate Finance Report Summary Al Jaber Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Eni SpA (ENI):企業の財務・戦略的SWOT分析
    Eni SpA (ENI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Dana Incorporated:戦略・SWOT・企業財務分析
    Dana Incorporated - Strategy, SWOT and Corporate Finance Report Summary Dana Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Punj Lloyd Ltd (PUNJLLOYD):企業の財務・戦略的SWOT分析
    Punj Lloyd Ltd (PUNJLLOYD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • CEMEX, SAB de CV:企業の戦略・SWOT・財務分析
    CEMEX, SAB de CV - Strategy, SWOT and Corporate Finance Report Summary CEMEX, SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Principia Biopharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Principia Biopharma Inc (Principia Biopharma) is a biopharmaceutical company that designs and develops oral small molecule drug therapies. The company’s proprietary Tailored Covalency technology helps to develop portfolio of drugs such as Bruton's tyrosine kinase (BTK) inhibitor, Interleukin …
  • Regulus Therapeutics Inc (RGLS):企業の財務・戦略的SWOT分析
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • Asahi Kasei Corp (3407)-医療機器分野:企業M&A・提携分析
    Summary Asahi Kasei Corp (Asahi Kasei), formerly Asahi Chemical Industry Co. Ltd., manufactures, processes, and sells chemical products. It is a holding company of Asahi Kasei Group. The product portfolio of the company includes polymers, acrylonitrile, styrene, diagnostic reagents, foam insulation …
  • APA Group:企業のM&A・事業提携・投資動向
    APA Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's APA Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Inotek Pharmaceuticals Corp (RCKT):製薬・医療:M&Aディール及び事業提携情報
    Summary Inotek Pharmaceuticals Corp (IPC) is a clinical-stage biopharmaceutical company that focus on the discovery and development of novel therapeutics for the treatment of glaucoma and serious diseases of the eye. The company’s trabodenoson is a selective adenosine mimetic that stimulates a speci …
  • Glow Energy Public Co Ltd:発電所・企業SWOT分析
    Glow Energy Public Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Wartsila Corp (WRT1V):企業の財務・戦略的SWOT分析
    Wartsila Corp (WRT1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Spectral Medical Inc (EDT):企業の財務・戦略的SWOT分析
    Summary Spectral Medical Inc (Spectral), formerly Spectral Diagnostics Inc, is a biotechnology company that develops and commercializes diagnostic solutions for patient management. The company’s products comprise EAA, toraymyxin and reagents, among others. Its EAA is an endotoxin activity assay, whi …
  • Nippon Paint (China) Co Ltd:企業の戦略・SWOT・財務分析
    Nippon Paint (China) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nippon Paint (China) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆